A phase III study (CheckMate 017) of nivolumab (NIVO; anti-programmed death-1 [PD-1]) vs docetaxel (DOC) in previously treated advanced or metastatic squamous (SQ) cell non-small cell lung cancer (NSCLC).

Author:

Spigel David R.1,Reckamp Karen L.2,Rizvi Naiyer A.3,Poddubskaya Elena4,West Howard Jack5,Eberhardt Wilfried Ernst Erich6,Baas Paul7,Antonia Scott Joseph8,Pluzanski Adam9,Vokes Everett E.10,Holgado Esther11,Waterhouse David Michael12,Ready Neal13,Gainor Justin F.14,Aren Osvaldo Rudy15,Horn Leora16,Paz-Ares Luis17,Baudelet Christine18,Lestini Brian Joseph18,Brahmer Julie R.19

Affiliation:

1. Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN

2. City of Hope National Medical Center, Duarte, CA

3. Memorial Sloan Kettering Cancer Center, New York, NY

4. N.N. Blokhin Russian Cancer Research Center, Moscow, Russia

5. Swedish Cancer Institute, Seattle, WA

6. Department of Medical Oncology, University Hospital Essen, West German Cancer Centre, Ruhrlandklinik, and University Duisburg-Essen, Essen, Germany

7. Antoni Van Leeuwenhoek Hospital, Amsterdam, Netherlands

8. H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

9. Centrum Onkologii - Instytut Im. Marii Sklodowskiej-Curie, Warsaw, Poland

10. University of Chicago Medical Center, Chicago, IL

11. Hospital de Madrid, Norte Sanchinarro, Spain

12. Oncology Hematology Care, Blue Ash, OH

13. Duke University Medical Center, Durham, NC

14. Massachusetts General Hospital Cancer Center, Boston, MA

15. Centro Internacional de Estudios Clinicos, Santiago, Chile

16. Vanderbilt University Medical Center, Nashville, TN

17. Hospital Universitario Virgen Del Rocio, Seville, Spain

18. Bristol-Myers Squibb, Princeton, NJ

19. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3